Xiaopeng Li - Net Worth and Insider Trading

Xiaopeng Li Net Worth

The estimated net worth of Xiaopeng Li is at least $482,859 dollars as of 2024-11-13. Xiaopeng Li is the Director of Oramed Pharmaceuticals Inc and owns about 206,350 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $482,859. Details can be seen in Xiaopeng Li's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Xiaopeng Li has not made any transactions after 2017-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Xiaopeng Li

To

Xiaopeng Li Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Xiaopeng Li owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of Xiaopeng Li’s form 4 insider trades.

Insider Ownership Summary of Xiaopeng Li

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2017-08-02 director

Xiaopeng Li Latest Holdings Summary

Xiaopeng Li currently owns a total of 1 stock. Xiaopeng Li owns 206,350 shares of Oramed Pharmaceuticals Inc (ORMP) as of August 2, 2017, with a value of $482,859.

Latest Holdings of Xiaopeng Li

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORMP Oramed Pharmaceuticals Inc 2017-08-02 206,350 2.34 482,859

Holding Weightings of Xiaopeng Li


Xiaopeng Li Form 4 Trading Tracker

According to the SEC Form 4 filings, Xiaopeng Li has made a total of 0 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 89,636 shares on August 2, 2017, which cost Xiaopeng Li around $761,906.

Insider Trading History of Xiaopeng Li

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Xiaopeng Li Trading Performance

GuruFocus tracks the stock performance after each of Xiaopeng Li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xiaopeng Li is 25.73%. GuruFocus also compares Xiaopeng Li's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xiaopeng Li within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Xiaopeng Li's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Xiaopeng Li

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.84 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.93 LIMIT LIMIT LIMIT LIMIT LIMIT

Xiaopeng Li Ownership Network

Ownership Network List of Xiaopeng Li

No Data

Ownership Network Relation of Xiaopeng Li

Insider Network Chart

Xiaopeng Li Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Xiaopeng Li is the director of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Xiaopeng Li Mailing Address

Above is the net worth, insider trading, and ownership report for Xiaopeng Li. You might contact Xiaopeng Li via mailing address: Floor11; No.266 Han Kou Road, Shanghai F4 200001.